Immunic | VTL - Equity Capital And Reserves


Immunic reported $10.5M in Equity Capital and Reserves for its fiscal quarter ending in September of 2025.





Equity Capital And Reserves Change Date
Alterity Therapeutics Limited AUD 36.21M 18.58M Dec/2025
BioMarin Pharmaceutical USD 6.09B 30.29M Dec/2025
Cipla INR 329.19B 16.3B Sep/2025
Clal Biotechnology ILS 121.41M 4.62M Dec/2023
Compugen USD 102.73M 58.9M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Enanta Pharmaceuticals USD 126.59M 61.87M Dec/2025
Grifols EUR 6.21B 133.12M Dec/2025
Immunic USD 10.5M 23.41M Sep/2025
Insmed USD 738.98M 206.6M Dec/2025
Omeros USD -228.68M 15.13M Jun/2025
OraSure Technologies USD 340.83M 21.15M Dec/2025
Quidel USD 1.92B 115.9M Dec/2025
Ultragenyx Pharmaceutical USD 9.16M 142.13M Sep/2025
United Therapeutics USD 7.1B 506M Dec/2025
Xoma USD 87.94M 15.5M Sep/2025